Recent Finacing
Recent Raise
Concerto Biosciences operates the kChip ultra-high-throughput discovery platform to design microbial ensembles, built a human skin microbe biobank, and is developing ENS-002 to modulate Staphylococcus aureus in atopic dermatitis.
